https://clinicaltrials.gov/ct2/show/NCT04507659?type=Intr
https://clinicaltrials.gov/ct2/show/NCT04507659?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=07%2F28%2F2020&lupd_d=14&sort=nwst
STUDY TITLE:
Jacketinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis
DESCRIPTION:
Condition: Ankylosing Spondylitis
Interventions: Drug: Jacketinib hydrochloride tablets; Drug: Placebo
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Not yet recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT04507659
FIRST POSTED:
Tue, 11 Aug 2020 12:00:00 EDT
LAST UPDATE POSTED:
08/11/20 06:51AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT04507659?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=07%2F28%2F2020&lupd_d=14&sort=nwst